Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

China flag China · Delayed Price · Currency is CNY
27.95
-0.44 (-1.55%)
Mar 9, 2026, 4:00 PM EDT
3.56%
Market Cap 4.54B
Revenue (ttm) 504.59M
Net Income (ttm) 213.50M
Shares Out 160.82M
EPS (ttm) 1.33
PE Ratio 21.28
Forward PE n/a
Dividend 1.40 (5.01%)
Ex-Dividend Date Oct 20, 2025
Volume 1,644,906
Average Volume 997,295
Open 28.11
Previous Close 28.39
Day's Range 27.87 - 28.40
52-Week Range 22.66 - 39.47
Beta n/a
RSI 30.89
Earnings Date Apr 22, 2026

About SHA:603207

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. produces and sells medicines in China. It offers medicines in the areas of gastroenterology, dermatology, orthopedics and traumatology, five senses, and disinfection. Shanghai Xiao Fang Pharmaceutical Co.,Ltd. was founded in 1993 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 1993
Employees 404
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603207
Full Company Profile

Financial Performance

In 2024, SHA:603207's revenue was 474.58 million, an increase of 0.57% compared to the previous year's 471.87 million. Earnings were 205.27 million, an increase of 0.81%.

Financial Statements

News

There is no news available yet.